Radiation Safety Considerations in the Treatment of Canine Skeletal Conditions Using 153Sm, 90Y, and 117mSn
The treatment of pets, service animals, and pre-clinical research subjects with radionuclides raises concern for the safety of the people who interact with the animals after their treatment. Three treatments of skeletal conditions in dogs are considered in this study: Sm-1,4,7,10-tetraazacylcododecanetetramethylenephosphonic acid, which is a bone-seeking radiopharmaceutical; unencapsulated Y permanent interstitial implants, which are sometimes called "liquid brachytherapy"; and Sn radiosynoviorthesis, which is also called radiosynovectomy. External exposure rate readings of the Sm and Sn treatments, and Monte Carlo simulations of Sn at a distance of 1 m and of all three in direct contact with tissue were analyzed for doses. Dogs that have received any of these treatments using typically administered activities may be released from radiation safety isolation immediately after treatment from the standpoint of external exposure. People should avoid prolonged close proximity, such as sleeping with a treated dog, for three weeks following an Y interstitial implant or for a month following Sn radiosynoviorthesis. No such avoidance is necessary after treatment with Sm-1,4,7,10-tetraazacylcododecanetetramethylenephosphonic acid.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:118 |
|---|---|
| Enthalten in: |
Health physics - 118(2020), 6 vom: 13. Juni, Seite 702-710 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wendt, Richard E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
13598-36-2 |
|---|
| Anmerkungen: |
Date Completed 02.04.2021 Date Revised 28.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/HP.0000000000001222 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30755600X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30755600X | ||
| 003 | DE-627 | ||
| 005 | 20240328233655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/HP.0000000000001222 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1352.xml |
| 035 | |a (DE-627)NLM30755600X | ||
| 035 | |a (NLM)32167498 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wendt, Richard E |c 3rd |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Radiation Safety Considerations in the Treatment of Canine Skeletal Conditions Using 153Sm, 90Y, and 117mSn |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2021 | ||
| 500 | |a Date Revised 28.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The treatment of pets, service animals, and pre-clinical research subjects with radionuclides raises concern for the safety of the people who interact with the animals after their treatment. Three treatments of skeletal conditions in dogs are considered in this study: Sm-1,4,7,10-tetraazacylcododecanetetramethylenephosphonic acid, which is a bone-seeking radiopharmaceutical; unencapsulated Y permanent interstitial implants, which are sometimes called "liquid brachytherapy"; and Sn radiosynoviorthesis, which is also called radiosynovectomy. External exposure rate readings of the Sm and Sn treatments, and Monte Carlo simulations of Sn at a distance of 1 m and of all three in direct contact with tissue were analyzed for doses. Dogs that have received any of these treatments using typically administered activities may be released from radiation safety isolation immediately after treatment from the standpoint of external exposure. People should avoid prolonged close proximity, such as sleeping with a treated dog, for three weeks following an Y interstitial implant or for a month following Sn radiosynoviorthesis. No such avoidance is necessary after treatment with Sm-1,4,7,10-tetraazacylcododecanetetramethylenephosphonic acid | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Phosphorous Acids |2 NLM | |
| 650 | 7 | |a phosphonic acid |2 NLM | |
| 650 | 7 | |a 13598-36-2 |2 NLM | |
| 700 | 1 | |a Selting, Kimberly A |e verfasserin |4 aut | |
| 700 | 1 | |a Lattimer, Jimmy C |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Janine |e verfasserin |4 aut | |
| 700 | 1 | |a Simón, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Stevenson, Nigel R |e verfasserin |4 aut | |
| 700 | 1 | |a Stearns, Stanley D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Health physics |d 1958 |g 118(2020), 6 vom: 13. Juni, Seite 702-710 |w (DE-627)NLM000004561 |x 1538-5159 |7 nnns |
| 773 | 1 | 8 | |g volume:118 |g year:2020 |g number:6 |g day:13 |g month:06 |g pages:702-710 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/HP.0000000000001222 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 118 |j 2020 |e 6 |b 13 |c 06 |h 702-710 | ||